| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-28 | FY 2024
FILED 2024-12-29 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $759.4M | $606.3M | $471.9M |
| YoY Revenue Growth % | +25.3% | +28.5% | — |
| Gross Profit | $285.7M | $229.9M | — |
| Gross Margin % | 37.6% | 37.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $88.4M | $63.6M | $33.3M |
| Operating Margin % | 11.6% | 10.5% | 7.0% |
| Net Income (GAAP) | $66.3M | $53.4M | $25.6M |
| EBITDA (Normalized) | $153.9M | $86.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $33.7M | $64.8M | $50.9M |
| Capital Expenditures (CapEx) | $82.0M | $28.6M | — |
| Free Cash Flow (FCF) | -$48.2M | $36.2M | $50.9M |
| FCF Margin % | -6.4% | 6.0% | 10.8% |
| Return on Invested Capital (ROIC %) | 23.1% | 42.3% | — |
| Cash & Short-Term Equivalents | $48.8M | $150.6M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $351.3M | $269.3M | — |